glp 1 va study Launches Nationwide Trial Of GLP-1 Drug For Problem Drinking GLP-1 drugs reduce addiction risk

A 2025 study published in Obesity found that GLP1 users lost 7.7% of body weight on semaglutide and 12.4% on tirzepatide after one year, roughly half the weight loss seen in randomized trials

These dinners are designed to: Support muscle preservation Keep portions comfortable, not restrictive Deliver steady energy and blood sugar balance Stay under 600 calories per serving A few important notes before you start: Cooking for more than one person

Build that into all your program designs

Great practical guide

Dosing varies

Its true appetite-suppressing power unlocks incrementally as the concentration of the medication builds safely in your bloodstream over successive weeks